Trial · NCT03442322
Optimizing Care for Patients With Dementia
NCT03442322, Not applicable, Completed, University of Pittsburgh; results first posted 2024-08-19
3 sourcestrials-2026-11-12-0.5.0
Download JSON
Cite this record
ConductScience Library. Optimizing Care for Patients With Dementia. Trials, record NCT03442322. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03442322
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Optimizing Care for Patients With Dementia
- NCT number
- NCT03442322
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 53 participants, actual
- Lead sponsor
- University of Pittsburgh
- Conditions
- Alzheimer Disease
- Interventions
- transdisciplinary approach, multidisciplinary approach
- First posted
- 2018-02-22
- Last updated
- 2024-08-19
- Results first posted
- 2024-08-19
- Limitations and caveats
We were only able to assess post-training outcomes for 6 months prior to COVID-19 and it is possible that nursing homes would have achieved different outcomes after this initial start-up period. Similarly, the comparative effectiveness of the care approaches in 12- and 18-month follow-up period were confounded by the effects of COVID-19. Finally, the use of antipsychotic medication outcome was collected with a 7-day look back period, which may have resulted in underreporting.
Source ClinicalTrials.gov
Registered outcomes24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Dispensing of Psychotropic Medications | 6-month period (months 1-6) | Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 1-6 of Intervention. |
| Primary | Dispensing of Psychotropic Medications | 12-month period (months 7-12) | Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 7-12 of Intervention. |
| Primary | Dispensing of Psychotropic Medications | 18-month period (months 13-18) | Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 13-18 of Intervention. |
| Primary | Behavioral Symptoms | 6-month period (months 1-6) | Percentage of nursing home residents with dementia who had behavioral symptoms over Months 1-6 of Intervention. |
| Primary | Behavioral Symptoms | 12-month period (months 7-12) | Percentage of nursing home residents with dementia who had behavioral symptoms over Months 7-12 of Intervention. |
| Primary | Behavioral Symptoms | 18-month period (months 13-18) | Percentage of nursing home residents with dementia who had behavioral symptoms over Months 13-18 of Intervention. |
| Primary | Wandering | 6-month period (months 1-6) | Percentage of nursing home residents with dementia who had wandering over Months 1-6 of Intervention. |
| Primary | Wandering | 12-month period (months 7-12) | Percentage of nursing home residents with dementia who had wandering over Months 7-12 of Intervention. |
| Primary | Wandering | 18-month period (months 13-18) | Percentage of nursing home residents with dementia who had wandering over Months 13-18 of Intervention. |
| Primary | Rejection of Care | 6-month period (months 1-6) | Percentage of nursing home residents with dementia who had rejection of care over Months 1-6 of Intervention. |
1 to 10 of 24Source ClinicalTrials.gov
See all 24 registered outcomesOutcomes24
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Dispensing of Psychotropic Medications | 6-month period (months 1-6) | Population includes all nursing home residents with dementia in participating nursing homes with valid data in the Minimum Data Set (MDS) assessments. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Dispensing of Psychotropic Medications | 12-month period (months 7-12) | Population includes all nursing home residents with dementia in participating nursing homes (NHs) with valid data in the Minimum Data Set (MDS) assessments. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Dispensing of Psychotropic Medications | 18-month period (months 13-18) | Population includes all nursing home residents with dementia in participating NHs with valid data in the Minimum Data Set (MDS) assessments. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Behavioral Symptoms | 6-month period (months 1-6) | Population includes all nursing home residents with dementia in participating NHs with valid data in the Minimum Data Set (MDS) assessments. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Behavioral Symptoms | 12-month period (months 7-12) | Population includes all nursing home residents with dementia in participating NHs with valid data in the Minimum Data Set (MDS) assessments. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Behavioral Symptoms | 18-month period (months 13-18) | Population includes all nursing home residents with dementia in participating NHs with valid data in the Minimum Data Set (MDS) assessments. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Wandering | 6-month period (months 1-6) | Population includes all nursing home residents with dementia in participating NHs with valid data in the Minimum Data Set (MDS) assessments. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Wandering | 12-month period (months 7-12) | Population includes all nursing home residents with dementia in participating NHs with valid data in the Minimum Data Set (MDS) assessments. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Wandering | 18-month period (months 13-18) | Population includes all nursing home residents with dementia in participating NHs with valid data in the Minimum Data Set (MDS) assessments. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Rejection of Care | 6-month period (months 1-6) | Population includes all nursing home residents with dementia in participating NHs with valid data in the Minimum Data Set (MDS) assessments. | Participants | COUNT_OF_PARTICIPANTS |
1 to 10 of 24Source ClinicalTrials.gov
See all 24 outcomesResults by group48
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Dispensing of Psychotropic Medications | Transdisciplinary Approach | 161 | Participants | ||
| Dispensing of Psychotropic Medications | Multidisciplinary Approach | 315 | Participants | ||
| Dispensing of Psychotropic Medications | Transdisciplinary Approach | 125 | Participants | ||
| Dispensing of Psychotropic Medications | Multidisciplinary Approach | 289 | Participants | ||
| Dispensing of Psychotropic Medications | Transdisciplinary Approach | 107 | Participants | ||
| Dispensing of Psychotropic Medications | Multidisciplinary Approach | 227 | Participants | ||
| Behavioral Symptoms | Transdisciplinary Approach | 143 | Participants | ||
| Behavioral Symptoms | Multidisciplinary Approach | 334 | Participants | ||
| Behavioral Symptoms | Transdisciplinary Approach | 104 | Participants | ||
| Behavioral Symptoms | Multidisciplinary Approach | 299 | Participants |
1 to 10 of 48Source ClinicalTrials.gov
See all 48 results by groupParticipant flow10
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Transdisciplinary Approach | 1,291 | 17 |
| Overall Study | STARTED | Multidisciplinary Approach | 3,206 | 36 |
| Overall Study | 6-month Outcome | Transdisciplinary Approach | 793 | 17 |
| Overall Study | 6-month Outcome | Multidisciplinary Approach | 1,905 | 36 |
| Overall Study | 12-month Outcome | Transdisciplinary Approach | 658 | 16 |
| Overall Study | 12-month Outcome | Multidisciplinary Approach | 1,693 | 36 |
| Overall Study | COMPLETED | Transdisciplinary Approach | 526 | 16 |
| Overall Study | COMPLETED | Multidisciplinary Approach | 1,420 | 36 |
| Overall Study | NOT COMPLETED | Transdisciplinary Approach | 765 | 1 |
| Overall Study | NOT COMPLETED | Multidisciplinary Approach | 1,786 | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Transdisciplinary Approach | 0 | 1,291 |
| Total, all-cause mortality | Multidisciplinary Approach | 0 | 3,206 |
| Total, other adverse events | Transdisciplinary Approach | 0 | 1,291 |
| Total, other adverse events | Multidisciplinary Approach | 0 | 3,206 |
| Total, serious adverse events | Transdisciplinary Approach | 0 | 1,291 |
| Total, serious adverse events | Multidisciplinary Approach | 0 | 3,206 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 37501632 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons26
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Transdisciplinary Approach vs Multidisciplinary Approach: Unintended Weight Loss | Trial comparisons |
| Transdisciplinary Approach vs Multidisciplinary Approach: Unintended Weight Loss | Trial comparisons |
| Transdisciplinary Approach vs Multidisciplinary Approach: Dispensing of Psychotropic Medications | Trial comparisons |
| Transdisciplinary Approach vs Multidisciplinary Approach: Rejection of Care | Trial comparisons |
| Transdisciplinary Approach vs Multidisciplinary Approach: Wandering | Trial comparisons |
| Transdisciplinary Approach vs Multidisciplinary Approach: Behavioral Symptoms | Trial comparisons |
| Transdisciplinary Approach vs Multidisciplinary Approach: Wandering | Trial comparisons |
| Transdisciplinary Approach vs Multidisciplinary Approach: Depressive Symptoms | Trial comparisons |
| Transdisciplinary Approach vs Multidisciplinary Approach: Falls | Trial comparisons |
| Transdisciplinary Approach vs Multidisciplinary Approach: Falls | Trial comparisons |
1 to 10 of 26
See all 26 trial comparisonsTests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03442322
GET https://conductscience.org/api/trials/v1/NCT03442322/registered?page=2